Abstract
Medullary renal cell carcinomas are exceedingly rare and essentially uniformly and rapidly fatal. Expeditious diagnosis is crucial. Immediate treatment with a clinical trial or platinum-based chemotherapy is needed for metastatic disease given the aggressive nature of medullary renal cell carcinomas. In this article, we discuss a 24-year-old man with no known significant past medical history who presented with a progressive cough and shortness of breath. After evaluation at an urgent care and four evaluations in the emergency department, the patient was admitted and ultimately diagnosed with metastatic medullary renal cell carcinoma. This case highlights the characteristics, presentation, rarity, and aggressiveness of medullary renal cell carcinoma.
References
Beckermann, K. E., Sharma, D., Chaturvedi, S., Msaouel, P., Abboud, M. R., Allory, Y.,...Rathmell, W. K. (2017). Renal medullary carcinoma: Establishing standards in practice. Journal of Oncology Practice, 13(7), 414–421. https://doi.org/10.1200/JOP.2017.020909
Davis, C. J., Jr., Mostofi, F. K., & Sesterhenn, I. A. (1995). Renal medullary carcinoma: The seventh sickle cell nephropathy. The American Journal of Surgical Pathology, 19(1), 1–11. https://doi.org/10.1097/00000478-199501000-00001
Elliott, A., & Bruner, E. (2019). Renal medullary carcinoma. Archives of Pathology & Laboratory Medicine, 143(12), 1556–1561. https://doi.org/10.5858/arpa.2017-0492-RS
Ezekian, B., Englum, B., Gilmore, B. F., Nag, U. P., Kim, J., Leraas, H. J.,...Tracy, E. T. (2017). Renal medullary carcinoma: A national analysis of 159 patients. Pediatric Blood & Cancer, 64(11), e26609. https://doi.org/10.1002/pbc.26609
Gopee-Ramanan, P., Chin, S., Lim, C., Shanbhogue, K. P., Schieda, N., & Krishna, S. (2022). Renal neoplasms in young adults. RadioGraphics, 42(2), 433–450. https://doi.org/10.1148/rg.210138
Neogenomics. (n.d.). Test menu. https://neogenomics.com/test-menu
Parker, N. A., Al-Obaidi, A., & Deutsch, J. M. (2020). SMARCB1/INI1-deficient tumors of adulthood. F1000Research, 9, 662. https://doi.org/10.12688/f1000research.24808.2
Pathology Outlines. (n.d.). Stains (IHC & special) & CD markers. https://www.pathologyoutlines.com/stains.html
Su, Y., & Hong, A. L. (2022). Recent advances in renal medullary carcinoma. International Journal of Molecular Sciences, 23(13), 7097. https://doi.org/10.3390/ijms23137097
Tretiakova, M. S. (2020). Renal cell tumors: Molecular findings reshaping clinico-pathological practice. Archives of Medical Research, 51(8), 799–816. https://doi.org/10.1016/j.arcmed.2020.08.003
